Global Healthcare Analyst

Tina Banerjee

Equity Bottom-Up

<ul>
<li>
<a href="https://www.smartkarma.com/entities/dong-a-st-co-ltd" target="_blank" data-smartkarma-citation="entities:16873:1" rel="noopener">Dong A St (170900 KS)</a> 1Q25 revenue rose 21% YoY, which is a significant improvement as the company recorded just 6% YoY growth in revenue in 2024.</li>
<li>Existing operation of Dong A St is showing strength. Stelara biosimilar to generate sales royalties from this year. Cenobamate launch is expected by next year.</li>
<li>Pipeline is promising, with upcoming data readouts expected through 2026. Obesity drug candidate has best-in-class potential.</li>
</ul>



Dong A St (170900 KS) 1Q25 revenue rose 21% YoY, which is a significant improvement as the company recorded just 6% YoY growth in revenue in 2024.
Existing operation of Dong A St is showing strength. Stelara biosimilar to generate sales royalties from this year. Cenobamate launch is expected by next year.
Pipeline is promising, with upcoming data readouts expected through 2026. Obesity drug candidate has best-in-class potential.


Dong A St (170900 KS): Five Reasons Why Performance Improvement Is Expected

United States

MetaVia Inc. operates as a clinical-stage biotechnology company. The Company focuses on developing dual oxyntomodulin (OXM) analog agonist for the treatment of obesity and metabolic dysfunction-associated steatohepatitis (MASH). MetaVia serves customers worldwide.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

MetaVia (MTVA US)

Dong A St (170900 KS): Five Reasons Why Performance Improvement Is Expected

Dong A St sees double-digit revenue growth in 1Q25. Strong existing operation and forthcoming launches to fuel growth. Pipeline is promising, with...

Tina Banerjee

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)

Dong A St (170900 KS): Five Reasons Why Performance Improvement Is Expected

​Dong A St sees double-digit revenue growth in 1Q25. Strong existing operation and forthcoming launches to fuel growth. Pipeline is promising, with...

Tina Banerjee

Dong A St sees double-digit revenue growth in 1Q25. Strong existing operation and forthcoming launches to fuel growth. Pipeline is promising, with...